

Collegium Pharmaceutical is a specialty pharmaceutical company focused on the development of products for the treatment of chronic pain. Among its major competitors, Collegium Pharmaceutical is ranked in 5th place for NPS while Biogen is 1st, and Athersys is 2nd.Their current market cap is $739.64M